Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125
- 1 November 1989
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 161 (5) , 1206-1212
- https://doi.org/10.1016/0002-9378(89)90667-4
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- "Sandwich"-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy.Clinical Chemistry, 1988
- An assay for the detection of human anti-murine immunoglubulins in the presence of CA125 antigenJournal of Immunological Methods, 1988
- OKT3 MONOCLONAL ANTIBODY PLASMA LEVELS DURING THERAPY AND THE SUBSEQUENT DEVELOPMENT OF HOST ANTIBODIES TO OKT3Transplantation, 1986
- Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3.The Journal of Immunology, 1986
- The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1986
- Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibodyJournal of Immunological Methods, 1985
- Human immune response to multiple injections of murine monoclonal IgG.The Journal of Immunology, 1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Use of staphylococcal protein A as an immunological reagentJournal of Immunological Methods, 1978